Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
June 03, 2024 01:30 ET
|
VALLOUREC
Press release Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities) Meudon (France), June 3rd 2024 – Vallourec, a world leader in premium tubular solutions, announces...
BGHL (EUR): NAV(s)
June 03, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Number of voting rights as of May 31, 2024
June 03, 2024 01:30 ET
|
NICOX SA
Nicox SA Société anonyme with a registered capital of € 502,996.94 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 BiotR.C.S. ANTIBES 403.942.642 On June 3rd,...
BW Energy: Fixed Income Investor Meetings
June 03, 2024 01:30 ET
|
BW Energy Limited
BW Energy: Fixed Income Investor Meetings BW Energy has engaged DNB Markets, a part of DNB Bank ASA and Pareto Securities AS as Joint Bookrunners to arrange a series of fixed income investor...
BGHL (GBP): NAV(s)
June 03, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
June 03, 2024 01:30 ET
|
Transgene S.A.
Patient screening and enrollment initiated for the Phase II part of the international randomized Phase I/II trial with an overall sample size of approximately 80 patients. Last patient enrollment for...
Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates
June 03, 2024 01:30 ET
|
Vidac Pharma Holding PLC
London (UK), June 3, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel...
BW Energy: Appraisal confirms material Hibiscus field reserve increase
June 03, 2024 01:25 ET
|
BW Energy Limited
BW Energy: Appraisal confirms material Hibiscus field reserve increase Reference is made to the stock exchange notice by BW Energy on 20 May 2024 announcing a substantial oil discovery on the...
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
June 03, 2024 01:00 ET
|
ALK Abello
At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which took part in Valencia in Spain from 31 May to 3 June 2024, the Danish pharmaceutical company ALK...
New data with daridorexant to be presented at SLEEP 2024
June 03, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Allschwil, Switzerland – June 3, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data with daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with insomnia,...
- June 03, 2024 00:02 ET NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
- June 03, 2024 00:00 ET IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth